TF expression in malignant cells is an independent prognostic factor of tumor progression and VTE risk across a range of cancer types, including pancreatic (244, 245), glioma (246), colorectal cancer (247), breast cancer (248), and non-small cell lung cancer (249, 250). The gene discussed is TF; the disease is breast carcinoma.